Hydroxy-ethyl-starches: Are the conclusions always evidence-based?

Intensive Care Medicine

Volumn 35, Issue 6, 2009, Pages 1147-

  Mion, Georges ^a   Libert, Nicolas ^a   Cirodde, Audrey ^a  

^a Ecole du Val de Grace   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DEXTRAN; GELATIN; HETASTARCH; PLASMA SUBSTITUTE;

ALLERGY; ENDOTHELIUM LESION; EVIDENCE BASED MEDICINE; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LETTER; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; NEPHROSIS; ONCOTIC PRESSURE; OSMOSIS; RENAL REPLACEMENT THERAPY; SEPSIS; STATISTICAL ANALYSIS;

EVIDENCE-BASED MEDICINE; FLUID THERAPY; HETASTARCH; HUMANS; RESEARCH DESIGN;

EID: 67349221774     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-009-1441-4     Document Type: Letter

References (5)

1. FM Brunkhorst C Engel F Bloos A Meier-Hellmann M Ragaller N Weiler O Moerer M Gruendling M Oppert S Grond D Olthoff U Jaschinski S John R Rossaint T Welte M Schaefer P Kern E Kuhnt M Kiehntopf C Hartog C Natanson M Loeffler K Reinhart German Competence Network Sepsis (SepNet) 2008 Intensive insulin therapy and pentastarch resuscitation in severe sepsis N Engl J Med 358 125 139
2. F Schortgen E Girou N Deye L Brochard for the CRYCO Study Group 2008 The risk associated with hyperoncotic colloids in patients with shock Intensive Care Med 34 2157 2168
3. Wiedermann CJ (2008) Resuscitation with hyperoncotic colloids in the intensive care unit. Intensive Care Med. doi: 10.1007/s00134-008-1378-z
4. C Sirtl H Laubenthal V Zumtobel D Kraft W Jurecka 1999 Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related Br J Anaesth 82 510 515 (Pubitemid 29151229)
5. M Dawes W Summerskill P Glasziou A Cartabellotta J Martin K Hopayian F Porzsolt A Burls J Osborne Second International Conference of Evidence-Based Health Care Teachers, Developers 2005 Sicily statement on evidence-based practice BMC Med Educ 5 1